Iterum Therapeutics rebounded from a 2021 Food and Drug Administration rejection to secure the approval of Orlynvah, an oral antibiotic for uncomplicated urinary tract infections, in […]

Generative AI tools can produce inconsistent outputs because server load and batching create subtle numerical differences that change phrasing over time. For pharma marketers, this nondeterminism […]

AI dominated the conversation at Fierce Pharma Week 2025, with leaders emphasizing its potential for predictive targeting, personalization and content creation while warning about the risks […]

In this excerpt from the Kinara podcast, Gilead Sciences SVP, corporate development Devang Bhuva lays out a blueprint for effective and impactful M&A in pharma. While […]

Pharma marketing is at a crossroads, with the old model of maximizing volume giving way to one focused on trust, relevance and quality of engagement. Physicians […]

OpenAI’s GPT-5 promises major leaps in reasoning and accuracy, with features like reduced hallucinations and an advanced routing system. For pharmaceutical marketers, it’s a powerful ideation […]

The women’s health space appears to be gaining momentum, courtesy of high-profile new treatments and more robust funding of femtech initiatives, But these advances often fail […]

Jay Donovan Wu, EVP and president, US, of Ascendis Pharma, shares how his personal journey shaped a leadership style grounded in empathy and urgency. He discusses […]

Dr. Kimberly Smith has spent nearly four decades on the front lines of the HIV/AIDS epidemic, evolving from a young physician offering comfort to dying patients […]